leisure time -WSS

leisure time

author：hotspot 2025-09-30 00:45:31 - browse：6

A black and white cutout photo of Feng Zhang on the left of a black and white cutout photo of Alex Aravanis. Both photos are placed on top of yellow geometric shapes and a gradient dark blue background. — Researcher Feng Zhang, left, and Alex Aravanis, the CEO of Moonwalk. Illustration: Christine Kao/STAT; Photo: Katherine Taylor for STAT and Business Wire

A new startup co-founded by CRISPR innovator Feng Zhang, a former executive at Grail and Illumina, and others has raised $57 million to develop a defanged form of gene editing that doesn’t cut the DNA strand.

Moonwalk Therapeutics launched Thursday with funding from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, Khosla Ventures, GV, and YK Bioventures. It plans to use that money to develop treatments for a variety of diseases, including chronic and aging-related conditions, using what’s called epigenetic editing.

Most of the gene editing technologies being used today slice or nick the DNA strand and make permanent changes to the biological building blocks of genes. Moonwalk, however, plans to alter the activity of genes by focusing on chemical changes. The company is targeting the surrounding chemicals that influence how genes act. This can be done through chemical processes methylation, which turns genes on, or demethylation, which turns genes off.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Alabama hospital puts IVF treatments on hold

WSS

ActiGraph execs on goal of drug approvals with digital endpoints

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Dario to buy mental health app maker Twill in cash and stock deal

An interview with Robert F. Kennedy Jr. on vaccines

Cancer drug shortages' outsize impact on ovarian cancer patients

New definition of a human embryo proposed amid rapid advances

focus

leisure time

leisure time

Activists slam private health insurers over coverage restrictions

Alabama frozen embryo ruling has major implications for IVF clinics

United colonoscopy coverage change 'may cost lives,' doctors say

As Maui death toll rises, number of missing remains unclear

Hollywood unions extend contract negotiations for actors

Trump's false claims about Georgia's 2020 election long debunked

Jerome Adams on the need for new antivirals for Covid

A new nitrogen execution bill also undermines medical licensing

At least 13 dead in Texas as scorching temps continue

A solution to the after

focus

Alabama IVF ruling threatens families facing fatal genetic disease

A solution to the after

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Ed Silverman on new gene therapies, biosimilars, coffee, and more

PBM reform efforts get punted in Congress

Listen: Racing for gene therapy & a pioneering approval

hotspot

leisure time

explore

entertainment